Free Trial
→ Trump Exec Order 14179 is wealth “gift” to good Americans? (From Paradigm Press) (Ad) Buy HCM Stock  Free HCM Stock Alerts

HUTCHMED (HCM) Financials

HUTCHMED logo
$13.40 +0.13 (+0.98%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$13.45 +0.05 (+0.37%)
As of 05/23/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for HUTCHMED

Annual Income Statements for HUTCHMED

This table shows HUTCHMED's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Income / (Loss) Attributable to Common Shareholders		 38 101 -361 -195 -126 -106 -75 -27 12 -35 -33
Consolidated Net Income / (Loss)		 38 101 -360 -167 -116 -104 -71 -23 15 10 -4.09
Net Income / (Loss) Continuing Operations		 38 101 -360 -167 -116 -104 -71 -23 15 10 -6.12
Total Pre-Tax Income 		-1.11 58 -410 -216 -190 -141 -87 -54 -47 -11 -20
Total Operating Income		 -44 18 -408 -328 -197 -146 -93 -53 -47 -9.77 -18
Total Gross Profit		 281 454 115 98 39 45 70 65 60 73 34
Total Revenue		 630 838 426 356 228 205 214 241 216 178 87
Operating Revenue		 630 838 426 356 - - 214 241 216 178 87
Total Cost of Revenue		 349 384 311 258 189 160 144 176 156 105 53
Operating Cost of Revenue		 349 384 311 258 189 160 144 176 156 105 53
Total Operating Expenses		 325 435 523 426 236 191 163 119 106 83 52
Selling, General & Admin Expense		 113 133 136 127 61 53 49 43 40 30 17
Research & Development Expense		 212 302 387 299 175 138 114 76 67 47 30
Total Other Income / (Expense), net		 43 40 -2.73 113 6.93 5.28 5.99 -0.12 -0.66 -0.77 -1.70
Interest Expense		 2.87 0.76 0.65 0.59 0.79 1.03 1.01 1.46 1.63 1.40 1.52
Interest & Investment Income		 40 36 9.60 123 3.24 4.94 5.98 1.22 0.50 0.45 0.56
Other Income / (Expense), net		 5.39 4.55 -12 -10 4.49 1.37 1.02 0.12 0.47 0.18 -0.74
Income Tax Expense		 7.19 4.51 -0.28 12 4.83 3.27 3.96 3.08 4.33 1.61 1.34
Other Gains / (Losses), net		 46 47 50 61 79 41 19 34 66 23 15
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.44 0.31 0.45 28 10 2.35 3.52 3.77 2.86 45 29
Basic Earnings per Share		 $0.04 $0.12 ($0.43) ($0.25) ($0.18) ($0.16) ($0.11) ($0.04) $0.20 ($0.64) -
Weighted Average Basic Shares Outstanding		 855.35M 849.65M 847.14M 792.68M 697.93M 665.68M 664.26M 617.17M 59.72M 54.66M 52.56M
Diluted Earnings per Share		 $0.04 $0.12 ($0.43) ($0.25) ($0.18) ($0.16) ($0.11) ($0.04) $0.20 ($0.64) -
Weighted Average Diluted Shares Outstanding		 872.83M 869.20M 847.14M 792.68M 697.93M 665.68M 664.26M 617.17M 59.97M 54.66M 52.56M
Weighted Average Basic & Diluted Shares Outstanding		 871.60M 871.26M 864.78M 864.53M 697.93M 665.68M 664.26M 617.17M 60.71M - -

Quarterly Income Statements for HUTCHMED

No quarterly income statements for HUTCHMED are available.

Annual Cash Flow Statements for HUTCHMED

This table details how cash moves in and out of HUTCHMED's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Change in Cash & Equivalents		 -130 -249 204 346 177 116 34 15 57 -7.01 -7.92
Net Cash From Operating Activities		 0.50 219 -269 -204 -62 -81 -33 -8.94 -9.57 -9.39 8.36
Net Cash From Continuing Operating Activities		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Income / (Loss) Continuing Operations		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Cash From Investing Activities		 -96 -291 297 -306 -125 119 44 -261 -34 8.86 -15
Net Cash From Continuing Investing Activities		 -96 -291 297 -306 -125 119 44 -261 -34 8.86 -15
Purchase of Property, Plant & Equipment		 -18 -33 -37 -16 -7.95 -8.57 -6.36 -5.02 -4.33 -3.32 -3.73
Acquisitions		 0.00 -8.09 0.00 0.00 - 8.69 -8.00 -7.00 -5.00 0.00 0.00
Purchase of Investments		 -1,849 -1,628 -1,202 -1,356 -733 -478 -904 -325 -81 0.00 -
Divestitures		 0.00 5.10 0.00 0.00 - 0.00 - 0.00 - - 0.69
Sale and/or Maturity of Investments		 1,769 1,343 1,518 921 629 597 962 76 57 12 8.86
Other Investing Activities, net		 1.28 29 17 145 -14 0.00 0.00 - - - -21
Net Cash From Financing Activities		 -31 49 -83 650 296 -1.49 -8.23 273 92 -5.47 -0.64
Net Cash From Continuing Financing Activities		 -31 49 -83 650 296 -1.49 -8.23 273 92 -5.47 -0.64
Repayment of Debt		 -31 0.00 -27 -0.58 0.00 -27 -32 -49 -29 -6.41 -14
Repurchase of Common Equity		 -36 -9.07 -48 -57 -21 -0.35 -6.19 -9.94 -14 -3.11 0.00
Payment of Dividends		 -1.00 -9.07 -26 -9.89 -1.46 -1.28 -1.28 -1.59 -0.56 -0.59 -1.18
Issuance of Debt		 36 62 18 0.00 0.00 27 27 33 25 3.21 8.21
Issuance of Common Equity		 0.79 5.09 0.17 717 319 0.25 3.87 302 111 1.37 5.74
Effect of Exchange Rate Changes		 -3.40 -6.47 -9.49 2.43 5.55 -1.50 -1.90 2.36 -1.78 -7.01 -0.42
Cash Interest Paid		 2.51 0.42 0.15 0.43 0.82 0.92 0.98 0.76 1.57 1.22 1.47
Cash Income Taxes Paid		 3.59 3.73 19 5.01 5.94 3.25 3.75 3.84 2.66 0.51 -0.91

Quarterly Cash Flow Statements for HUTCHMED

No quarterly cash flow statements for HUTCHMED are available.

Annual Balance Sheets for HUTCHMED

This table presents HUTCHMED's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Total Assets		 1,274 1,280 1,029 1,373 724 465 532 598 342 230
Total Current Assets		 1,067 1,097 840 1,212 531 317 371 432 167 90
Cash & Equivalents		 154 284 313 378 236 121 86 85 79 32
Short-Term Investments		 682 603 318 634 200 96 215 273 24 0.00
Note & Lease Receivable		 0.00 0.00 0.00 - - - - - - -
Accounts Receivable		 163 145 99 84 48 68 44 51 46 48
Inventories, net		 50 50 57 36 20 16 12 12 13 9.56
Other Current Assets		 17 15 53 81 28 16 13 11 4.31 -
Plant, Property, & Equipment, net		 92 100 76 41 24 21 17 14 9.95 8.51
Total Noncurrent Assets		 115 83 114 119 169 127 145 152 165 132
Long-Term Investments		 83 48 74 76 140 99 138 144 159 120
Noncurrent Deferred & Refundable Income Taxes		 12 15 15 9.40 1.52 0.82 0.58 0.63 0.00 -
Other Noncurrent Operating Assets		 20 19 24 33 28 11 1.36 1.65 1.77 6.58
Total Liabilities & Shareholders' Equity		 1,274 1,280 1,029 1,373 724 465 532 598 342 230
Total Liabilities		 502 536 393 333 205 152 120 113 138 127
Total Current Liabilities		 377 403 354 312 158 113 85 105 95 81
Short-Term Debt		 23 31 0.00 27 0.00 - - 30 20 23
Accounts Payable		 43 36 71 41 32 24 26 31 41 57
Current Deferred Revenue		 50 58 13 - - 2.11 2.54 1.30 0.96 1.17
Current Deferred & Payable Income Tax Liabilities		 1.55 2.58 1.11 16 1.12 1.83 0.56 0.98 1.64 0.31
Other Current Liabilities		 259 275 268 228 126 85 56 41 32 -
Total Noncurrent Liabilities		 126 133 39 21 47 39 34 8.37 43 46
Long-Term Debt		 59 48 18 0.00 27 27 27 0.00 27 27
Noncurrent Deferred Revenue		 48 69 0.19 - - 0.13 0.41 2.80 4.30 5.63
Noncurrent Deferred & Payable Income Tax Liabilities		 2.99 1.48 2.71 2.77 5.06 3.16 4.84 4.45 4.00 3.42
Other Noncurrent Operating Liabilities		 15 14 18 19 15 9.01 2.40 1.12 8.13 10
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 772 743 637 1,040 519 313 412 485 204 102
Total Preferred & Common Equity		 760 731 610 987 484 288 389 462 184 83
Total Common Equity		 760 731 610 987 484 288 389 462 184 83
Common Stock		 1,605 1,610 1,584 1,592 895 582 572 563 269 170
Retained Earnings		 -833 -871 -971 -610 -416 -290 -183 -107 -80 -92
Accumulated Other Comprehensive Income / (Loss)		 -12 -8.16 -1.90 5.57 4.48 -3.85 -0.24 5.43 -4.28 5.02
Noncontrolling Interest		 12 13 27 53 35 25 23 23 20 19

Quarterly Balance Sheets for HUTCHMED

No quarterly balance sheets for HUTCHMED are available.

Annual Metrics And Ratios for HUTCHMED

This table displays calculated financial ratios and metrics derived from HUTCHMED's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -24.80% 96.52% 19.73% 56.21% 11.27% -4.31% -11.23% 11.63% 21.26% 104.06% 0.00%
EBITDA Growth		 -267.15% 105.47% -23.88% -76.15% -32.52% -58.28% -71.90% -15.30% -382.18% 49.54% 0.00%
EBIT Growth		 -267.15% 105.47% -23.88% -76.15% -32.52% -58.28% -71.90% -15.30% -382.18% 49.54% 0.00%
NOPAT Growth		 -280.45% 105.94% -24.18% -66.94% -34.35% -58.01% -73.43% -14.39% -377.91% 46.49% 0.00%
Net Income Growth		 -62.24% 128.05% -115.75% -44.60% -11.42% -45.44% -210.44% -257.75% 39.61% 355.19% 0.00%
EPS Growth		 -66.67% 127.91% -72.00% -38.89% -12.50% -45.45% -175.00% -120.00% 131.25% 0.00% 0.00%
Operating Cash Flow Growth		 -99.77% 181.63% -31.52% -229.04% 23.29% -146.33% -267.29% 6.54% -1.96% -212.27% 0.00%
Free Cash Flow Firm Growth		 -199.02% 130.76% -8.62% -178.13% 32.58% -142.27% 14.74% -192.65% -187.73% 0.00% 0.00%
Invested Capital Growth		 42.67% -124.94% -128.86% 24.63% -222.29% 8,685.09% -102.21% 209.33% -2,772.94% 0.00% 0.00%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 44.64% 54.12% 27.04% 27.49% 17.31% 21.84% 32.77% 27.11% 27.65% 41.16% 38.76%
EBITDA Margin		 -6.08% 2.74% -98.35% -95.06% -84.30% -70.78% -42.79% -22.10% -21.39% -5.38% -21.76%
Operating Margin		 -6.94% 2.19% -95.61% -92.19% -86.27% -71.45% -43.27% -22.15% -21.61% -5.48% -20.91%
EBIT Margin		 -6.08% 2.74% -98.35% -95.06% -84.30% -70.78% -42.79% -22.10% -21.39% -5.38% -21.76%
Profit (Net Income) Margin		 6.06% 12.06% -84.52% -46.90% -50.67% -50.60% -33.29% -9.52% 6.74% 5.85% -4.68%
Tax Burden Percent		 -3,448.06% 173.38% 87.81% 77.43% 60.88% 73.48% 82.26% 42.89% -30.74% -98.93% 20.47%
Interest Burden Percent		 2.89% 254.38% 97.87% 63.73% 98.73% 97.30% 94.58% 100.44% 102.44% 109.94% 105.04%
Effective Tax Rate		 0.00% 7.73% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% -878.29% -1,067.91% -7,055.08% 0.00% -3,218.68% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% -877.95% -1,066.45% -7,059.27% 0.00% -3,252.59% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 849.70% 1,052.02% 7,048.41% 0.00% 3,239.07% 0.00%
Return on Equity (ROE)		 5.04% 14.65% -43.00% -21.44% -27.77% -28.59% -15.89% -6.67% 9.50% 20.39% 0.00%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% -535.20% 0.00% -492.53% 0.00% -3,418.68% 0.00%
Operating Return on Assets (OROA)		 -3.00% 1.99% -34.92% -32.29% -32.32% -29.08% -16.22% -11.34% -16.16% -4.18% 0.00%
Return on Assets (ROA)		 2.99% 8.76% -30.01% -15.93% -19.43% -20.79% -12.62% -4.88% 5.09% 4.54% 0.00%
Return on Common Equity (ROCE)		 4.96% 14.23% -40.97% -20.23% -25.78% -26.70% -15.07% -6.25% 8.30% 16.62% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 5.02% 13.84% -59.04% -16.93% -23.86% -36.00% -18.33% -4.97% 7.90% 12.51% 0.00%
Net Operating Profit after Tax (NOPAT)		 -31 17 -285 -230 -138 -102 -65 -37 -33 -6.84 -13
NOPAT Margin		 -4.85% 2.02% -66.93% -64.53% -60.39% -50.01% -30.29% -15.50% -15.13% -3.84% -14.64%
Net Nonoperating Expense Percent (NNEP)		 8.13% 10.91% -8.58% 7.80% 5.29% -0.34% -1.45% 4.19% 29.78% 33.91% 0.00%
Return On Investment Capital (ROIC_SIMPLE)		 -3.58% 2.06% -43.57% - - - - - - - -
Cost of Revenue to Revenue		 55.36% 45.88% 72.96% 72.51% 82.69% 78.16% 67.23% 72.89% 72.35% 58.84% 61.24%
SG&A Expenses to Revenue		 17.92% 15.89% 31.92% 35.70% 26.91% 25.84% 22.72% 17.94% 18.32% 16.74% 19.27%
R&D to Revenue		 33.66% 36.04% 90.73% 83.98% 76.66% 67.45% 53.32% 31.31% 30.95% 26.58% 34.25%
Operating Expenses to Revenue		 51.57% 51.93% 122.65% 119.68% 103.57% 93.28% 76.04% 49.25% 49.26% 46.64% 59.67%
Earnings before Interest and Taxes (EBIT)		 -38 23 -419 -339 -192 -145 -92 -53 -46 -9.59 -19
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -38 23 -419 -339 -192 -145 -92 -53 -46 -9.59 -19
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.30 4.29 4.19 5.17 8.82 1.16 0.79 1.04 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)		 3.30 4.29 4.19 5.17 8.82 1.16 0.80 1.05 0.00 0.00 0.00
Price to Revenue (P/Rev)		 3.98 3.74 5.99 14.34 18.73 1.63 1.43 1.98 0.00 0.00 0.00
Price to Earnings (P/E)		 66.55 31.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 1.50% 3.22% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 2.96 0.00 2.36 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 2.68 2.73 4.45 11.50 16.48 0.34 0.00 0.12 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 99.89 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 99.89 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 135.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 3,394.00 10.44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 28.92 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.11 0.11 0.03 0.03 0.05 0.09 0.06 0.06 0.23 0.49 0.00
Long-Term Debt to Equity		 0.08 0.06 0.03 0.00 0.05 0.09 0.06 0.00 0.13 0.26 0.00
Financial Leverage		 -1.12 -1.12 -1.04 -1.03 -1.01 -0.97 -0.99 -1.00 -1.04 -1.00 0.00
Leverage Ratio		 1.69 1.67 1.43 1.35 1.43 1.38 1.26 1.36 1.87 2.24 0.00
Compound Leverage Factor		 0.05 4.26 1.40 0.86 1.41 1.34 1.19 1.37 1.91 2.47 0.00
Debt to Total Capital		 9.69% 9.64% 2.76% 2.52% 4.92% 7.89% 6.09% 5.82% 18.65% 32.77% 0.00%
Short-Term Debt to Total Capital		 2.73% 3.79% 0.00% 2.52% 0.00% 0.00% 0.00% 5.82% 7.96% 15.17% 0.00%
Long-Term Debt to Total Capital		 6.95% 5.86% 2.76% 0.00% 4.92% 7.89% 6.09% 0.00% 10.70% 17.60% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 1.40% 1.56% 4.05% 4.93% 6.38% 7.33% 5.30% 4.51% 7.89% 12.44% 0.00%
Common Equity to Total Capital		 88.92% 88.79% 93.19% 92.54% 88.70% 84.78% 88.61% 89.67% 73.46% 54.80% 0.00%
Debt to EBITDA		 -2.16 3.46 -0.04 -0.08 -0.14 -0.18 -0.29 -0.56 -1.01 -5.20 0.00
Net Debt to EBITDA		 21.82 -37.32 1.64 3.13 2.85 1.99 4.50 8.87 4.66 10.62 0.00
Long-Term Debt to EBITDA		 -1.55 2.10 -0.04 0.00 -0.14 -0.18 -0.29 0.00 -0.58 -2.79 0.00
Debt to NOPAT		 -2.71 4.68 -0.06 -0.12 -0.20 -0.26 -0.41 -0.80 -1.43 -7.29 0.00
Net Debt to NOPAT		 27.33 -50.45 2.41 4.62 3.98 2.82 6.36 12.64 6.59 14.89 0.00
Long-Term Debt to NOPAT		 -1.94 2.84 -0.06 0.00 -0.20 -0.26 -0.41 0.00 -0.82 -3.91 0.00
Altman Z-Score		 3.13 3.92 2.22 8.81 11.74 0.38 1.53 3.06 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio		 1.63% 2.85% 4.72% 5.61% 7.18% 6.64% 5.18% 6.24% 12.64% 18.50% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.83 2.72 2.37 3.89 3.35 2.80 4.33 4.13 1.76 1.10 0.00
Quick Ratio		 2.65 2.56 2.06 3.51 3.05 2.52 4.03 3.91 1.58 0.98 0.00
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -78 79 -257 -237 -85 -126 -52 -61 -21 -7.26 0.00
Operating Cash Flow to CapEx		 2.77% 672.32% -732.60% -1,245.19% -780.80% -944.68% -516.14% -178.18% -221.15% -282.34% 224.16%
Free Cash Flow to Firm to Interest Expense		 -27.30 104.31 -394.70 -400.22 -108.24 -122.67 -51.69 -42.04 -12.82 -5.17 0.00
Operating Cash Flow to Interest Expense		 0.17 288.88 -411.96 -344.97 -78.86 -78.56 -32.55 -6.15 -5.87 -6.68 5.51
Operating Cash Flow Less CapEx to Interest Expense		 -6.07 245.91 -468.19 -372.68 -88.96 -86.87 -38.86 -9.60 -8.52 -9.05 3.05
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.49 0.73 0.36 0.34 0.38 0.41 0.38 0.51 0.76 0.78 0.00
Accounts Receivable Turnover		 4.08 6.86 4.67 5.42 3.94 3.67 4.52 4.97 4.60 3.73 0.00
Inventory Turnover		 6.93 7.19 6.73 9.30 10.48 11.23 11.95 14.29 13.97 10.97 0.00
Fixed Asset Turnover		 6.56 9.54 7.28 10.88 10.13 10.94 13.89 19.96 23.41 20.95 0.00
Accounts Payable Turnover		 8.85 7.16 5.54 7.10 6.74 6.36 5.01 4.87 3.21 1.86 0.00
Days Sales Outstanding (DSO)		 89.42 53.21 78.14 67.36 92.66 99.52 80.69 73.38 79.34 97.84 0.00
Days Inventory Outstanding (DIO)		 52.65 50.77 54.23 39.24 34.83 32.50 30.55 25.55 26.12 33.26 0.00
Days Payable Outstanding (DPO)		 41.25 51.00 65.87 51.44 54.15 57.41 72.83 74.98 113.65 196.69 0.00
Cash Conversion Cycle (CCC)		 100.83 52.98 66.49 55.16 73.33 74.60 38.41 23.95 -8.19 -65.59 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -64 -112 -50 -22 -29 24 -0.28 12 -11 0.43 0.00
Invested Capital Turnover		 -7.15 -10.36 -11.92 -14.07 -86.65 17.56 35.26 455.10 -39.52 838.60 0.00
Increase / (Decrease) in Invested Capital		 48 -62 -28 7.11 -52 24 -13 24 -12 0.43 0.00
Enterprise Value (EV)		 1,687 2,290 1,895 4,097 3,758 70 -82 29 0.00 0.00 0.00
Market Capitalization		 2,511 3,132 2,556 5,106 4,271 334 307 479 0.00 0.00 0.00
Book Value per Share		 $0.87 $0.84 $0.71 $1.36 $0.69 $4.32 $5.85 $7.61 $3.09 $1.53 $0.00
Tangible Book Value per Share		 $0.87 $0.84 $0.71 $1.36 $0.69 $4.32 $5.80 $7.54 $3.03 $1.45 $0.00
Total Capital		 855 823 655 1,066 546 340 439 515 251 152 0.00
Total Debt		 83 79 18 27 27 27 27 30 47 50 0.00
Total Long-Term Debt		 59 48 18 0.00 27 27 27 0.00 27 27 0.00
Net Debt		 -836 -855 -687 -1,061 -548 -289 -413 -473 -215 -102 0.00
Capital Expenditures (CapEx)		 18 33 37 16 7.95 8.57 6.36 5.02 4.33 3.32 3.73
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -123 -161 -145 -84 -63 -13 -16 -0.71 -11 -0.41 0.00
Debt-free Net Working Capital (DFNWC)		 713 725 486 927 372 204 285 358 92 32 0.00
Net Working Capital (NWC)		 690 694 486 900 372 204 285 328 72 8.45 0.00
Net Nonoperating Expense (NNE)		 -69 -84 75 -63 -22 1.21 6.44 -14 -47 -17 -8.70
Net Nonoperating Obligations (NNO)		 -836 -855 -687 -1,061 -548 -289 -413 -473 -215 -102 0.00
Total Depreciation and Amortization (D&A)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital to Revenue		 -19.48% -19.26% -34.01% -23.69% -27.56% -6.47% -7.42% -0.30% -5.31% -0.23% 0.00%
Debt-free Net Working Capital to Revenue		 113.20% 86.51% 113.97% 260.39% 163.33% 99.53% 133.14% 148.25% 42.68% 17.69% 0.00%
Net Working Capital to Revenue		 109.49% 82.79% 113.97% 252.84% 163.33% 99.53% 133.14% 135.82% 33.44% 4.74% 0.00%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.04 $0.12 ($0.43) ($0.25) ($0.18) ($0.16) ($1.13) ($0.43) $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 855.35M 849.65M 847.14M 792.68M 727.72M 666.91M 66.43M 61.72M 59.72M 0.00 0.00
Adjusted Diluted Earnings per Share		 $0.04 $0.12 ($0.43) ($0.25) ($0.18) ($0.16) ($1.13) ($0.43) $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 872.83M 869.20M 847.14M 792.68M 727.72M 666.91M 66.43M 61.72M 59.97M 0.00 0.00
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 ($0.18) ($0.16) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 871.60M 871.26M 864.78M 864.53M 697.93M 665.68M 66.66M 66.45M 60.71M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 -31 17 -285 -230 -138 -102 -65 -37 -33 -6.84 -13
Normalized NOPAT Margin		 -4.85% 2.02% -66.93% -64.53% -60.39% -50.01% -30.29% -15.50% -15.13% -3.84% -14.64%
Pre Tax Income Margin		 -0.18% 6.96% -96.25% -60.58% -83.23% -68.87% -40.47% -22.20% -21.92% -5.91% -22.85%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -13.34 30.20 -643.20 -571.85 -244.20 -140.80 -90.81 -36.63 -28.34 -6.83 -12.53
NOPAT to Interest Expense		 -10.65 22.34 -437.71 -388.21 -174.93 -99.49 -64.27 -25.70 -20.04 -4.87 -8.43
EBIT Less CapEx to Interest Expense		 -19.59 -12.77 -699.44 -599.55 -254.30 -149.11 -97.11 -40.08 -31.00 -9.20 -14.99
NOPAT Less CapEx to Interest Expense		 -16.90 -20.63 -493.94 -415.92 -185.03 -107.80 -70.58 -29.15 -22.69 -7.24 -10.89
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 2.62% 8.97% -7.10% -5.92% -1.27% -1.24% -1.80% -6.94% 3.87% 5.66% -28.85%
Augmented Payout Ratio		 97.10% 17.94% -20.47% -39.94% -19.48% -1.57% -10.48% -50.24% 96.68% 35.46% -28.85%

Quarterly Metrics And Ratios for HUTCHMED

No quarterly metrics and ratios for HUTCHMED are available.

Frequently Asked Questions About HUTCHMED's Financials

When does HUTCHMED's fiscal year end?

According to the most recent income statement we have on file, HUTCHMED's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has HUTCHMED's net income changed over the last 10 years?

HUTCHMED's net income appears to be on an upward trend, with a most recent value of $38.17 million in 2024, falling from -$4.09 million in 2014. The previous period was $101.09 million in 2023. See HUTCHMED's forecast for analyst expectations on what’s next for the company.

What is HUTCHMED's operating income?
HUTCHMED's total operating income in 2024 was -$43.71 million, based on the following breakdown:
  • Total Gross Profit: $281.32 million
  • Total Operating Expenses: $325.02 million
How has HUTCHMED revenue changed over the last 10 years?

Over the last 10 years, HUTCHMED's total revenue changed from $87.33 million in 2014 to $630.20 million in 2024, a change of 621.6%.

How much debt does HUTCHMED have?

HUTCHMED's total liabilities were at $502.34 million at the end of 2024, a 6.3% decrease from 2023, and a 294.5% increase since 2015.

How much cash does HUTCHMED have?

In the past 9 years, HUTCHMED's cash and equivalents has ranged from $31.94 million in 2015 to $377.54 million in 2021, and is currently $153.96 million as of their latest financial filing in 2024.

How has HUTCHMED's book value per share changed over the last 10 years?

Over the last 10 years, HUTCHMED's book value per share changed from 0.00 in 2014 to 0.87 in 2024, a change of 87.2%.


Related Companies

This page (NASDAQ:HCM) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners
Trump Predicts Dollar Downfall
READ THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...
Augusta Precious Metals | Sponsored
$19 for a FULL YEAR of stock picks?!
Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...
Behind the Markets | Sponsored
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...
Paradigm Press | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Elon just did WHAT!?
As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...
Brownstone Research | Sponsored
The Hidden Energy Source Backed by Billionaires
Why Billionaires Have Set Their Sights on the Utah Desert Something strange is happening near the Wah Wah ...
Stansberry Research | Sponsored
After Monday, price goes up 600% (hurry)
Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...
Timothy Sykes | Sponsored
We’ve Entered the Most Bullish Phase of the Cycle
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...
Crypto Swap Profits | Sponsored